STOCK TITAN

Insider sale notice for DGX (DGX): Plewman lists proposed share disposals

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Form 144 notice: proposed dispositions of common stock by an insider and a restricted-stock vesting. The filing lists a restricted stock vesting of 410 shares on 02/23/2026 recorded as compensation. It also shows proposed sales by Thomas P. Plewman of 5,662 shares on 02/10/2026 and 958 shares on 02/19/2026 with corresponding aggregate dollar amounts disclosed in the excerpt.

Positive

  • None.

Negative

  • None.

Insights

Routine Form 144 notice for proposed disposition and compensation-related vesting.

The filing records a restricted stock vesting of 410 shares on 02/23/2026 described as compensation, and two proposed dispositions by Thomas P. Plewman: 5,662 shares on 02/10/2026 and 958 shares on 02/19/2026.

These entries are procedural notifications under resale rules; cash‑flow treatment and final execution details are not included in the excerpt. Subsequent broker reports or Form 4/Form 5 filings will show completion and exact sale methods.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the DGX Form 144 filing report?

It reports proposed dispositions and a restricted-stock vesting. The excerpt lists a 410-share restricted vesting on 02/23/2026 and proposed sales of 5,662 and 958 shares by Thomas P. Plewman on 02/10/2026 and 02/19/2026.

Who is the insider named in the DGX excerpt?

The filing shows transactions attributed to Thomas P. Plewman. The excerpt lists proposed dispositions of 5,662 shares and 958 shares on 02/10/2026 and 02/19/2026, respectively, with aggregate dollar amounts shown.

Does the filing show shares vesting as compensation for DGX?

Yes. The excerpt records a restricted stock vesting of 410 shares dated 02/23/2026 and labels the transaction type as Compensation in the securities-to-be-sold section.

Are aggregate dollar amounts disclosed in the excerpt?

Yes. The excerpt shows aggregate amounts linked to the proposed dispositions: one row lists 1155048.00 and another lists 196227.14 associated with the Thomas P. Plewman entries dated 02/10/2026 and 02/19/2026.

Does this Form 144 confirm sales were completed?

No. It is a notice of proposed dispositions. The excerpt lists dates and quantities but does not confirm execution; completion would be reflected in subsequent broker reports or Form 4/Form 5 filings.
Quest Diagnostics Inc

NYSE:DGX

View DGX Stock Overview

DGX Rankings

DGX Latest News

DGX Latest SEC Filings

DGX Stock Data

22.41B
109.04M
Diagnostics & Research
Services-medical Laboratories
Link
United States
SECAUCUS